Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus

Journal of Medical Virology

Volumn 66, Issue 3, 2002, Pages 335-339

  Gerna, Giuseppe ^a   Percivalle, Elena ^a   Baldanti, Fausto ^a   Revello, Maria Grazia ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cytomegalovirus; Endothelial cell tropism; Polymorphonuclear leukocyte tropism; Vaccine

Indexed keywords

CYTOMEGALOVIRUS VACCINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE MODEL; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; UMBILICAL VEIN; VACCINATION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOMEGALOVIRUS; DNA, VIRAL; ENDOTHELIUM, VASCULAR; HUMANS; NEUTROPHILS; PHOSPHOPROTEINS; RNA, VIRAL; UMBILICAL VEINS; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0036156971     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2150     Document Type: Article

References (16)

1. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications
2. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
3. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins
4. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia
5. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro generated pp65-positive peripheral blood polymorphonuclear leukocytes
6. Human cytomegalovirus leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection
7. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients
8. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events
9. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil endothelial cell contact and during neutrophil transendothelial migration
10. Defined large-scale alteration of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids
11. Vaccination against cytomegalovirus, the changeling demon
12. Candidate cytomegalovirus strain for human vaccination
13. Protective effect of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge
14. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia and leukoDNAemia
15. In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells
16. Towne/Toledo vaccine development